COST-EFFECTIVENESS OF IRINOTECAN (CPT-11) AND BEST ESTIMATED CHEMOTHERAPY REGIMEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER AFTER FAILURE OF 5FLUOROURACIL (5FU) CONTAINING REGIMEN - RESULTS BASED ON A PHASE-III TRIAL

Authors
BLIJHAM G SCHMITT C AUSSAGE P HENRYLAUNOIS B JOLAIN B HERAIT P
Citation
G. Blijham et al., COST-EFFECTIVENESS OF IRINOTECAN (CPT-11) AND BEST ESTIMATED CHEMOTHERAPY REGIMEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER AFTER FAILURE OF 5FLUOROURACIL (5FU) CONTAINING REGIMEN - RESULTS BASED ON A PHASE-III TRIAL, European journal of cancer, 33, 1997, pp. 4-4
Citations number
NO
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
9
Pages
4 - 4
Database
ISI
SICI code
0959-8049(1997)33:<4:COI(AB>2.0.ZU;2-B